2-amino-4-[12-[(2-amino-4-pyridinyl)methyl]-13-(2-cyanocyclopropyl)-6-fluoro-3-methoxy-10-oxa-2,4,8,13-tetrazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-7-yl]-1-benzothiophene-3-carbonitrile;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine
C36H34F2N10O2S — CID 177217041
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-amino-4-[12-[(2-amino-4-pyridinyl)methyl]-13-(2-cyanocyclopropyl)-6-fluoro-3-methoxy-10-oxa-2,4,8,13-tetrazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-7-yl]-1-benzothiophene-3-carbonitrile;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine
2-amino-4-[12-[(2-amino-4-pyridinyl)methyl]-13-(2-cyanocyclopropyl)-6-fluoro-3-methoxy-10-oxa-2,4,8,13-tetrazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-7-yl]-1-benzothiophene-3-carbonitrile;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine (PubChem CID 177217041) has the molecular formula C36H34F2N10O2S and a molecular weight of 708.80 g/mol. Its IUPAC name is 2-amino-4-[12-[(2-amino-4-pyridinyl)methyl]-13-(2-cyanocyclopropyl)-6-fluoro-3-methoxy-10-oxa-2,4,8,13-tetrazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-7-yl]-1-benzothiophene-3-carbonitrile;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine.
Molecular Properties
| Compound Name | 2-amino-4-[12-[(2-amino-4-pyridinyl)methyl]-13-(2-cyanocyclopropyl)-6-fluoro-3-methoxy-10-oxa-2,4,8,13-tetrazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-7-yl]-1-benzothiophene-3-carbonitrile;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine |
|---|---|
| PubChem CID | 177217041 |
| Molecular Formula | C36H34F2N10O2S |
| Molecular Weight | 708.80 g/mol |
| Exact Mass | 708.26 |
| IUPAC Name | 2-amino-4-[12-[(2-amino-4-pyridinyl)methyl]-13-(2-cyanocyclopropyl)-6-fluoro-3-methoxy-10-oxa-2,4,8,13-tetrazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-7-yl]-1-benzothiophene-3-carbonitrile;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine |
| SMILES | COc1nc2c3c(nc(-c4cccc5sc(N)c(C#N)c45)c(F)c3n1)OCC(Cc1ccnc(N)c1)N2C1CC1C#N.FC1CC2CCCN2C1 |
| InChI | InChI=1S/C29H22FN9O2S.C7H12FN/c1-40-29-37-25-22-27(38-29)39(18-9-14(18)10-31)15(7-13-5-6-35-20(33)8-13)12-41-28(22)36-24(23(25)30)16-3-2-4-19-21(16)17(11-32)26(34)42-19;8-6-4-7-2-1-3-9(7)5-6/h2-6,8,14-15,18H,7,9,12,34H2,1H3,(H2,33,35);6-7H,1-5H2 |
| InChIKey | WZJBPACNDJBUGV-UHFFFAOYSA-N |
| XLogP | 5.40 |
| TPSA | 176.12 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 708.80 |
| LogP ≤ 5 | 5.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177217041 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.